Popular Arthritis Drug For Dogs May Have Severe Side Effects, F.D.A. SaysLibrela, a drug for canine arthritis, may cause severe neurological effects, raising safety concerns despite its approval and marketing by Zoetis.
Lilly's Alzheimer's drug faces delayed reckoningFDA advisers are reviewing Eli Lilly's Alzheimer's drug application, impacting future treatments targeting amyloid plaques.